Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$0.18 - $0.86 $6,249 - $29,856
-34,717 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$0.6 - $1.06 $1,309 - $2,312
2,182 Added 6.71%
34,717 $21,000
Q4 2021

Feb 09, 2022

SELL
$0.85 - $1.4 $6,928 - $11,411
-8,151 Reduced 20.03%
32,535 $29,000
Q3 2021

Nov 09, 2021

BUY
$1.33 - $1.77 $13,031 - $17,342
9,798 Added 31.72%
40,686 $54,000
Q2 2021

Aug 10, 2021

SELL
$1.41 - $1.94 $10,139 - $13,950
-7,191 Reduced 18.88%
30,888 $44,000
Q1 2021

May 10, 2021

SELL
$1.61 - $2.77 $9,676 - $16,647
-6,010 Reduced 13.63%
38,079 $69,000
Q4 2020

Feb 08, 2021

BUY
$1.55 - $2.24 $25,953 - $37,506
16,744 Added 61.23%
44,089 $77,000
Q3 2020

Nov 06, 2020

SELL
$1.91 - $3.08 $2,481 - $4,000
-1,299 Reduced 4.53%
27,345 $53,000
Q2 2020

Aug 05, 2020

BUY
$1.97 - $3.98 $22,918 - $46,303
11,634 Added 68.4%
28,644 $79,000
Q1 2020

May 12, 2020

SELL
$1.17 - $3.0 $2,029 - $5,205
-1,735 Reduced 9.26%
17,010 $51,000
Q4 2019

Feb 05, 2020

SELL
$1.16 - $1.42 $2,407 - $2,946
-2,075 Reduced 9.97%
18,745 $23,000
Q3 2019

Nov 13, 2019

BUY
$1.21 - $1.65 $5,808 - $7,920
4,800 Added 29.96%
20,820 $28,000
Q2 2019

Aug 12, 2019

BUY
$1.39 - $2.03 $1,007 - $1,471
725 Added 4.74%
16,020 $27,000
Q1 2019

May 10, 2019

SELL
$1.39 - $1.71 $2,337 - $2,876
-1,682 Reduced 9.91%
15,295 $23,000
Q4 2018

Feb 14, 2019

SELL
$1.41 - $2.16 $2,640 - $4,045
-1,873 Reduced 9.94%
16,977 $24,000
Q3 2018

Nov 14, 2018

BUY
$1.86 - $2.18 $3,803 - $4,458
2,045 Added 12.17%
18,850 $40,000
Q2 2018

Aug 13, 2018

BUY
$1.76 - $2.79 $4,792 - $7,597
2,723 Added 19.34%
16,805 $0
Q1 2018

May 14, 2018

SELL
$1.34 - $2.03 $2,200 - $3,333
-1,642 Reduced 10.44%
14,082 $26,000
Q4 2017

Feb 13, 2018

BUY
$1.65 - $2.45 $1,212 - $1,800
735 Added 4.9%
15,724 $28,000
Q3 2017

Nov 02, 2017

BUY
$1.5 - $2.55 $22,483 - $38,221
14,989
14,989 $31,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.